Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/bcp.13167 http://scihub22266oqcxt.onion/10.1111/bcp.13167 C5346876!5346876!27780288     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Br+J+Clin+Pharmacol 2017 ; 83 (4): 923-6 Nephropedia Template TP {{tp|p=27780288|t=2017. The use of incretins and fractures ? a meta?analysis on population?based real life data |pdf=|usr=}}{{27780288}} gab.com Text The use of incretins and fractures a meta analysis on population based real life data JO: Br J Clin Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=27780288 #FOAvip The aim of the present study was to estimate the effect of incretins on fracture risk in the real?world situation by meta?analysis of the available population?based cohort data. Pubmed and Embase were searched for original articles investigating use of incretin agents, and fracture risk up to December 2015. Adjusted results were extracted and pooled by use of generic inverse variance methods, assuming a random?effects model. Neither current dipeptidyl peptidase 4?inhibitor use nor current glucagon?like peptide 1 receptor agonist use was associated with a decreased risk of fracture: pooled relative risk (pooled RR [95% confidence interval]: 1.02 [0.91?1.13] and 1.03 [0.87?1.22]), respectively. This meta?analysis demonstrated that current use of incretin agents, was not associated with decreased fracture risk. Our findings show the value of representative real?world populations, and the risks associated with suggesting benefits for medications on the basis of safety reporting in randomized controlled trials. Twit Text FOAVip The use of incretins and fractures a meta analysis on population based real life data ????Br J Clin Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=27780288 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27780288 #FOAvip English Wikipedia <ref>{{Cite pmid|27780288}}</ref> The use of incretins and fractures ? a meta?analysis on population?based real life data #MMPMID27780288 Driessen JHM; de Vries F; van Onzenoort H; Harvey NC; Neef C; van den Bergh JPW; Vestergaard P; Henry RMA Br J Clin Pharmacol 2017[Apr]; 83 (4): 923-6 PMID27780288show ga The aim of the present study was to estimate the effect of incretins on fracture risk in the real?world situation by meta?analysis of the available population?based cohort data. Pubmed and Embase were searched for original articles investigating use of incretin agents, and fracture risk up to December 2015. Adjusted results were extracted and pooled by use of generic inverse variance methods, assuming a random?effects model. Neither current dipeptidyl peptidase 4?inhibitor use nor current glucagon?like peptide 1 receptor agonist use was associated with a decreased risk of fracture: pooled relative risk (pooled RR [95% confidence interval]: 1.02 [0.91?1.13] and 1.03 [0.87?1.22]), respectively. This meta?analysis demonstrated that current use of incretin agents, was not associated with decreased fracture risk. Our findings show the value of representative real?world populations, and the risks associated with suggesting benefits for medications on the basis of safety reporting in randomized controlled trials. äThe use of incretins and fractures ? a meta?analysis on population?bas(epmc).pdf DeepDyve Pubget Overpricing